These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30576922)

  • 1. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase.
    Battelli MG; Bortolotti M; Polito L; Bolognesi A
    Redox Biol; 2019 Feb; 21():101070. PubMed ID: 30576922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
    Battelli MG; Bortolotti M; Polito L; Bolognesi A
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidoreductase in cancer: more than a differentiation marker.
    Battelli MG; Polito L; Bortolotti M; Bolognesi A
    Cancer Med; 2016 Mar; 5(3):546-57. PubMed ID: 26687331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.
    Battelli MG; Polito L; Bolognesi A
    Atherosclerosis; 2014 Dec; 237(2):562-7. PubMed ID: 25463089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
    Furuhashi M
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The double faced role of xanthine oxidoreductase in cancer.
    Chen MM; Meng LH
    Acta Pharmacol Sin; 2022 Jul; 43(7):1623-1632. PubMed ID: 34811515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?
    Polito L; Bortolotti M; Battelli MG; Bolognesi A
    Pharmacol Res; 2022 Oct; 184():106407. PubMed ID: 35995347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans.
    Washio KW; Kusunoki Y; Murase T; Nakamura T; Osugi K; Ohigashi M; Sukenaga T; Ochi F; Matsuo T; Katsuno T; Moriwaki Y; Yamamoto T; Namba M; Koyama H
    Metabolism; 2017 May; 70():51-56. PubMed ID: 28403945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.
    Kelley EE
    Arch Toxicol; 2015 Aug; 89(8):1193-207. PubMed ID: 25995007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.
    Liu N; Xu H; Sun Q; Yu X; Chen W; Wei H; Jiang J; Xu Y; Lu W
    Oxid Med Cell Longev; 2021; 2021():1470380. PubMed ID: 33854690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.
    Chen C; Lü JM; Yao Q
    Med Sci Monit; 2016 Jul; 22():2501-12. PubMed ID: 27423335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.
    Agarwal A; Banerjee A; Banerjee UC
    Crit Rev Biotechnol; 2011 Sep; 31(3):264-80. PubMed ID: 21774633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome.
    Fujishima Y; Kita S; Nishizawa H; Maeda N; Shimomura I
    Endocr J; 2023 Jul; 70(7):663-675. PubMed ID: 37316258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme.
    Battelli MG; Bolognesi A; Polito L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1502-17. PubMed ID: 24882753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.
    Ichida K; Amaya Y; Okamoto K; Nishino T
    Int J Mol Sci; 2012 Nov; 13(11):15475-95. PubMed ID: 23203137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidoreductase promotes the progression of colitis-associated colorectal cancer by causing DNA damage and mediating macrophage M1 polarization.
    Li H; Zhang C; Zhang H; Li H
    Eur J Pharmacol; 2021 Sep; 906():174270. PubMed ID: 34171392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthine Oxidoreductase in the Pathogenesis of Endothelial Dysfunction: An Update.
    Mudgal R; Singh S
    Curr Hypertens Rev; 2024; 20(1):10-22. PubMed ID: 38318826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.
    Furuhashi M; Higashiura Y; Koyama M; Tanaka M; Murase T; Nakamura T; Akari S; Sakai A; Mori K; Ohnishi H; Saitoh S; Shimamoto K; Miura T
    Hypertens Res; 2021 Sep; 44(9):1213-1220. PubMed ID: 34117403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules.
    Ohtsubo T; Matsumura K; Sakagami K; Fujii K; Tsuruya K; Noguchi H; Rovira II; Finkel T; Iida M
    Hypertension; 2009 Oct; 54(4):868-76. PubMed ID: 19667249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidoreductase: One enzyme for multiple physiological tasks.
    Bortolotti M; Polito L; Battelli MG; Bolognesi A
    Redox Biol; 2021 May; 41():101882. PubMed ID: 33578127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.